These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7552485

  • 61. Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II.
    Liu H, Shah M, Stramer SL, Chen W, Weiblen BJ, Murphy EL.
    Transfusion; 1999; 39(11-12):1185-93. PubMed ID: 10604244
    [Abstract] [Full Text] [Related]

  • 62. The epidemiology and disease outcomes of human T-lymphotropic virus type II.
    Roucoux DF, Murphy EL.
    AIDS Rev; 2004; 6(3):144-54. PubMed ID: 15595431
    [Abstract] [Full Text] [Related]

  • 63. Failure to detect genomic material of HTLV-I or HTLV-II in mononuclear cells of Italian patients with multiple sclerosis and chronic progressive myelopathy.
    Merelli E, Sola P, Marasca R, Salati R, Torelli G.
    Eur Neurol; 1993; 33(1):23-6. PubMed ID: 8440281
    [Abstract] [Full Text] [Related]

  • 64. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z, Al-Bahrani AT, Panhotra BR.
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [Abstract] [Full Text] [Related]

  • 65. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis.
    Azarpazhooh MR, Hasanpour K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati-Moghaddam MR, Valizadeh N, Farid Hosseini R, Foroghipoor M, Soltanifar A, Sahebari M, Azadmanesh K, Hassanshahi G, Rafatpanah H.
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1095-1101. PubMed ID: 22229796
    [Abstract] [Full Text] [Related]

  • 66. Prevalence and genetic characterisation of HTLV-1 and 2 dual infections in patients with pulmonary tuberculosis in Central-West Brazil.
    Kozlowski AG, Carneiro MA, Matos MA, Teles SA, Araújo JA, Otsuki K, Vicente AC, Martins RM.
    Mem Inst Oswaldo Cruz; 2014 Feb; 109(1):118-21. PubMed ID: 24141955
    [Abstract] [Full Text] [Related]

  • 67. Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil.
    Jacob F, Santos-Fortuna Ede L, Azevedo RS, Caterino-de-Araujo A.
    Rev Inst Med Trop Sao Paulo; 2007 Feb; 49(6):361-4. PubMed ID: 18157402
    [Abstract] [Full Text] [Related]

  • 68. High prevalence of human T-lymphotropic virus (HTLV) infection in pregnant women in southern France.
    Vignoli C, De Lamballerie X, Zandotti C, De Chesse R, Tamalet C, De Micco P.
    Eur J Epidemiol; 1995 Feb; 11(1):93-4. PubMed ID: 7489782
    [No Abstract] [Full Text] [Related]

  • 69. HTLV-I/II as a common etiology of myelopathies in Bahia, Brazil.
    Andrade-Filho AS, Brites C, dos-Santos SR, Harrington Júnior W, Reinhardt IC, Freitas FM, Silva MC, Badaró R.
    Braz J Med Biol Res; 1996 Jun; 29(6):757-61. PubMed ID: 9070387
    [Abstract] [Full Text] [Related]

  • 70. HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors.
    Bellei NC, Granato CF, Tomyiama H, Castelo A, Ferreira O.
    Trans R Soc Trop Med Hyg; 1996 Jun; 90(2):122-5. PubMed ID: 8761567
    [Abstract] [Full Text] [Related]

  • 71. HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease.
    Soldan SS, Graf MD, Waziri A, Flerlage AN, Robinson SM, Kawanishi T, Leist TP, Lehky TJ, Levin MC, Jacobson S.
    J Infect Dis; 1999 Sep; 180(3):685-94. PubMed ID: 10438355
    [Abstract] [Full Text] [Related]

  • 72. Leads from the MMWR. Licensure of screening tests for antibody to human T-lymphotropic virus type I.
    JAMA; 1989 Jan 27; 261(4):513, 518-20, 525. PubMed ID: 2642562
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II.
    Biglione MM, Pizarro M, Salomón HE, Berría MI.
    Clin Infect Dis; 2003 Aug 01; 37(3):456-8. PubMed ID: 12884173
    [Abstract] [Full Text] [Related]

  • 76. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.
    Lal RB, Heneine W, Rudolph DL, Present WB, Hofhienz D, Hartley TM, Khabbaz RF, Kaplan JE.
    J Clin Microbiol; 1991 Oct 01; 29(10):2253-8. PubMed ID: 1939580
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA, Eirin ME, Pando MA, Biglione MM.
    J Med Virol; 2007 Jan 01; 79(1):69-73. PubMed ID: 17133550
    [Abstract] [Full Text] [Related]

  • 80. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC, Caramelli P, Martins ML, Gonçalves DU, Proietti FA, Ribas JG, Araújo MG, Carneiro-Proietti AB.
    AIDS Res Hum Retroviruses; 2013 Sep 01; 29(9):1199-202. PubMed ID: 23617363
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.